In deze samenvatting worden de leerdoelen per onderwerp uitgewerkt, die gegeven zijn in de cursuswijzer van FA-MA105.
De samenvatting begint met een hoofdstuk met algemene informatie: afkomstig uit het inleidende hoorcollege.
Daarna wordt de leerstof uit de werkcolleges per thema samengevat: Gene...
,Inhoud
Algemeen ........................................................................................................................................................ 5
Leerdoelen....................................................................................................................................................... 6
Schriftelijk tentamen ................................................................................................................................... 6
Geneesmiddelonderzoek ................................................................................................................................ 7
Waar speelt evidence een rol...................................................................................................................... 7
Bijwerkingen ................................................................................................................................................ 8
Dilemma ...................................................................................................................................................... 8
Patiëntpopulatie .......................................................................................................................................... 8
Type I en II fouten ....................................................................................................................................... 8
Het zorginstituut Nederland (ZIN) ............................................................................................................... 9
Evidence based medicine .......................................................................................................................... 10
Coronavaccin ............................................................................................................................................. 10
Onderzoeksopzet (study-design)................................................................................................................... 11
Randomised clinical trial (RCT) ...................................................................................................................... 12
Randomisatie............................................................................................................................................. 12
Blok randomisatie/ stratificeren 1:1 ratio ............................................................................................. 12
Gestratificeerde randomisatie .............................................................................................................. 12
Observationeel onderzoek ............................................................................................................................ 13
Cohort onderzoek...................................................................................................................................... 13
Case-control onderzoek ............................................................................................................................ 14
Cohort Vs. Case-control............................................................................................................................. 14
Analyse ...................................................................................................................................................... 15
Propensity score ........................................................................................................................................ 15
Schatting propensity-score.................................................................................................................... 15
Gebruik propensity score ...................................................................................................................... 15
Voordelen propensity score .................................................................................................................. 16
Nadelen propensity score ..................................................................................................................... 16
Rapporteren .......................................................................................................................................... 16
Case report/ Case series & Case-crossover studie ........................................................................................ 17
Case report/ Case series ............................................................................................................................ 17
Case-crossover studie................................................................................................................................ 17
Effectmaten & effectmodificatie in geneesmiddelonderzoek ...................................................................... 20
Effectmaten cohortonderzoek .................................................................................................................. 20
Effectmaten case-control onderzoek ........................................................................................................ 21
Effectmodificatie ....................................................................................................................................... 22
Primaire en secundaire eindpunten .......................................................................................................... 22
Composite outcome: samengestelde uitkomst ........................................................................................ 22
Kaplan-Meier curve ................................................................................................................................... 23
2
,Bias & Confounding ....................................................................................................................................... 25
Selectiebias................................................................................................................................................ 25
Informatiebias ........................................................................................................................................... 25
Confounding .............................................................................................................................................. 25
Corrigeren voor confounding – COX-regressie...................................................................................... 25
Voorkomen van confounding – matching, restrictie, stratificatie ........................................................ 26
Misclassificatie .......................................................................................................................................... 26
Immeasurable time bias ............................................................................................................................ 26
Immortal time bias .................................................................................................................................... 27
Time-window bias ..................................................................................................................................... 27
Time-lag bias ............................................................................................................................................. 27
Analyse .......................................................................................................................................................... 28
Intention to treat analyse.......................................................................................................................... 28
Per protocol analyse.................................................................................................................................. 28
Interim analyse .......................................................................................................................................... 29
Wetenschappelijke integriteit ....................................................................................................................... 30
Vergoedingsbeleid......................................................................................................................................... 33
Modelleren .................................................................................................................................................... 35
Markov model ........................................................................................................................................... 35
A. Vaststellen van de modelstructuur .............................................................................................. 35
B. Vaststellen van de transitiekansen ............................................................................................... 36
C. Vaststellen van de kosten en utiliteiten ....................................................................................... 36
D. Vaststellen van de behandeleffecten ........................................................................................... 37
E. Bouwen van de verdeling van patiënten (de Markov trace) gedurende de tijdshorizon voor
vergelijkende behandeling .................................................................................................................... 37
F. Bouwen van de verdeling van patiënten gedurende de tijdshorizon voor de nieuwe behandeling
38
G. Eventueel verdisconteren ............................................................................................................. 38
H. Berekenen van de kosten voor de oude en nieuwe behandeling ................................................ 39
I. Berekenen van de ICER ................................................................................................................. 39
J. Uitvoeren van de deterministische sensitiviteitsanalyse ............................................................. 40
K. Uitvoeren van de probabilistische sensitiviteitsanalyse ............................................................... 40
L. Uitvoeren van aanvullende analyses, zoals een cost-effectiveness acceptability frontier,
scenario analyses en value of information analyses ............................................................................. 42
Kritisch beoordelen observationele studies .................................................................................................. 44
De kwaliteit van individuele studies beoordelen ...................................................................................... 44
De beoordeling door ZIN ........................................................................................................................... 44
Farmacotherapeutische beoordeling bij ZIN ......................................................................................... 44
Farmaco-economische beoordeling bij ZIN........................................................................................... 44
Eindoordeel van ZIN .............................................................................................................................. 47
3
, 4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Michelle1802. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $11.30. You're not tied to anything after your purchase.
